Concentrix Corporation
CNXC
$37.35
-$0.91-2.38%
NASDAQ
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.29% | 4.01% | 1.54% | -1.27% | 9.74% |
| Total Other Revenue | -- | -- | -- | -- | 9.18% |
| Total Revenue | 4.29% | 4.01% | 1.54% | -1.27% | 9.74% |
| Cost of Revenue | 6.31% | 6.89% | 3.03% | -1.93% | 12.04% |
| Gross Profit | 0.62% | -1.06% | -1.10% | -0.07% | 5.80% |
| SG&A Expenses | -5.39% | 3.59% | 2.41% | -1.56% | 82.00% |
| Depreciation & Amortization | -2.11% | -4.10% | -5.87% | -- | -48.75% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.42% | 5.47% | 2.40% | -1.82% | 19.29% |
| Operating Income | 116.99% | -12.87% | -8.90% | 5.58% | -81.23% |
| Income Before Tax | -1,380.87% | 321.88% | -40.64% | 38.40% | 46.42% |
| Income Tax Expenses | 1,310.09% | 138.47% | -52.56% | 47.36% | -136.00% |
| Earnings from Continuing Operations | -1,379.19% | 429.79% | -37.02% | 34.85% | 66.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,379.19% | 429.79% | -37.02% | 34.85% | 66.43% |
| EBIT | 116.99% | -12.87% | -8.90% | 5.58% | -81.23% |
| EBITDA | 20.95% | -8.74% | -7.75% | -3.69% | -43.26% |
| EPS Basic | -1,475.47% | 439.10% | -35.77% | 36.80% | 57.73% |
| Normalized Basic EPS | 1,041.88% | 80.70% | -28.55% | 35.95% | -102.16% |
| EPS Diluted | -1,476.27% | 439.08% | -35.77% | 36.99% | 57.91% |
| Normalized Diluted EPS | 1,041.88% | 80.62% | -28.54% | 36.15% | -102.16% |
| Average Basic Shares Outstanding | -3.49% | -3.19% | -2.93% | -2.48% | 3.99% |
| Average Diluted Shares Outstanding | -3.55% | -3.16% | -2.95% | -2.62% | 3.87% |
| Dividend Per Share | 8.17% | 10.02% | 10.02% | 10.02% | 10.02% |
| Payout Ratio | -1.08% | -0.80% | 0.73% | -0.19% | -0.34% |